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ited moderate decrease in VIII:C level, one case manifested slight
decline in physical ability, one case manifested slight decline in
joint function. Meanwhile, both the decreasing of HIV RNA load
and the increasing of CD4+ T cell count were notable (P<0.05). It
is showed no statistics change could be seen in complete blood
cell count after 6 years of HAART, however, the mean hemoglobin
level of all 39 patients had decreased slightly blow normal range.
It also showed, serum alanine aminitransperase (ALT) increased
to a level which moderately above normal span but without
statistics signiﬁcance, however, triglyceride and uric acid were
markedly higher compared with the data before HAART (P<0.05);
no statistics difference could be seen in aspartate transaminase
(AST), serum bilirubin (SB), blood amylase, blood urea nitrogen,
blood creatinine and fasting plasma glucose (P>0.05).
Conclusion: Long term HAART is likely to have limited im-
pact on haemorrhage status, joint function and physical ability
in Haemophilia A/AIDS patients; however, HAART therapy is
effective to inhibit HIV replication and promote CD4+ cells prolif-
eration which indicates HAART is positive for immune recovery,
moreover, Long term HAART could induce animia, hepatic dam-
age, hyperlipidemia and hyperuricemia and which may widely
exist.
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Aims: Individuals who are diagnosed as HIV-positive tend to
change behavior to reduce transmission to others. The aims of
this work are to estimate the expected epidemiological impacts
of increasing HIV testing rates; to determine what testing levels
are required for serosorting to be an effective risk reduction
strategy for HIV-negative individuals; and to recommend optimal
testing rates for different settings and epidemics.
Methods: Extensive reviews were carried out of the social-
behavioral, biological, clinical, and epidemiological HIV litera-
ture relevant to numerous countries. These diverse data sources
were incorporated into mathematical models that simulated
complex mixing patterns and polymorphous sexual and injecting
behaviors among numerous population subgroups, the transmis-
sion of HIV throughout the population, along with tracking of
the disease progression and clinical outcomes of HIV-infected
individuals. The models were used to simulate the past and cur-
rent trends of HIV epidemics, identify key drivers, and forecast
expected future trends according to current conditions and due
to implementation of targeted intervention strategies focused
on voluntary counseling and testing (VCT) and routine screen-
ing. The models were coupled with uncertainty and sensitivity
analyses.
Results: There is a disproportionate association between undiag-
nosed status and HIV transmission. For example, it is estimated
that in Australia, where testing rates are relatively high, ap-
proximately 30% of new HIV infections are transmitted from the
∼10-15% of HIV infections that are undiagnosed. Similar dispro-
portionate associations exist in other locations. Even modest
increases in HIV testing rates could have substantial epidemi-
ological consequences in all settings, particularly in countries
where rates are currently low.
Surprisingly, it was found that the practice of serosorting to
reduce the risk of HIV acquisition likely increases the risk of HIV
in most settings; testing rates would need to be sufﬁciently high
such that the proportion of infections that are undiagnosed is
less than 20% for serosorting to be effective.
The appropriate goals for testing frequency and coverage rates
vary considerably between locations. However, increases in cov-
erage among the right target groups, if accompanied by even
relatively small behavior change, can be sufﬁcient to lead to sig-
niﬁcant public health control of HIV epidemics. In most settings,
public health goals should be at least regular annual testing of
individuals at relatively high risk and up to 4 times per year
for individuals at very high risk of HIV infection. Testing-based
interventions can be expected to have a noticeable impact within
a few years and the beneﬁts will also increase over time.
Conclusions: Promoting increases in the coverage and frequency
of HIV testing, particularly among people at high risk, could
be a highly-effective public health intervention. It is important
to provide easy access to VCT sites and make HIV screening a
more regular and routine component of clinical consultations.
This must be coupled with educational messages that encour-
age testing and make it more acceptable within given cultural
environments.
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Long-term success with Highly Active Antiretroviral therapy
(HAART) is a realistic and achievable goal for people living with
HIV-1 infection even in resource limited settings. There is now
ever growing evidence of continuing improvements in the clinical
management and treatment outcomes of people living with HIV-1
infection. This has facilitated our understanding of the contribut-
ing factors that determine durable success. The epidemiologic
evidence of success with HAART in suppressing HIV-1 replication
and preventing AIDS progression and death is now overwhelming.
Walensky et al estimated that 2.3 million life-years were saved
by antiretroviral therapy in the United States from 1996-2004.
A key determinant in ensuring long-term success is the selec-
tion of the initial antiretroviral regimen. The “ideal” regimen
should have high potency, convenient dosing, and minimal short
as well as long-term adverse effects. Of equal importance is the
timeliness of treatment initiation which has been recommended
to commence before the development of AIDS deﬁning events.
Various strategies to ensure optimal medication adherence and
patient participation has been utilized to maximize good clinical
outcome. These adherence programs must be consistent and
acceptable to local culture and practice. Often family and com-
munity support has been used as tools to achieve good medical
adherence. This is of particular importance in countries with
limited second-line antiretroviral options; where most patients
realistically have but one therapeutic chance to achieve good and
sustained viral suppression. Speciﬁc attention to comorbidities
including drug use, that may affect treatment outcomes must
also be considered and addressed. The HAART experience from
countries with limited resources will be discussed to illustrate
the above key information.
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The world’s ﬁrst nationwide hepatitis B virus (HBV) universal vac-
